NorthWest Biotherapeutics Inc (NWBO)

[Judge Smails 40]

Different View and couple more Indicators telling interesting story:
1. Aroon Oscilator is STILL riding the CENTERLINE! Thas has now been @ 0 looking for direction since May 10 Apocalypse!! I have never seen anything like this. 21 WEEKS On Centerline! WOW..This is wild.
2. TSI(Similar to MACD) with nice Higher Lows Trend Line in tact.
3. Weekly Candle with the Standard Back Test after breakout. Thumbs up
4. CMF Chaikin Money Flow with the Outlier Topping Wedge May 10. Now we see the Inverse with the Bottoming Outlier Big Whiplash last couple weeks. Thumbs up

[hoffmann6383]

#3,

my investment is based off of the state of events in 2022. if someone wants to base investments off of 2011 forward looking statements that is up to them

have a good one buddy

[Poor Man -]

The higher the better, but I own enough shares that $2 would guaranty me a bed and hot shower for life. That’s nothing to sneeze at, and I’m loathe to let that slip away again.

[Hopeforthefuture3]

Poor Man, $2 a share right now sound pretty good, I may part with some shares there as well but still hoping for $5 or better for the bigger portion of my shares

[Hopeforthefuture3]

Hoffman, think you missed the point- according to Linda Powers in 2011 we were on "the home stretch" turns out it was a long home stretch. Let's see what q4 of 2022 may bring

[biosectinvestor]

And they get the treatment in the doctor’s office, not hospitalized and with virtually no side-effects. I doubt regulators will look at it as you do.

Quality of life is improved, the potential for patients to live longer is established and has a compensatory value as well, some substantial patients will live many months longer than the few you indicated and that also has compensatory value, and then one looks at the alternatives, which is not “nothing” else.

I doubt very much that regulators are going to find reasons to say no on DCVax-L as part of the new standard of care and the new SOC for recurrent patients.

But you can argue in the abstract all that you’d like.

[biosectinvestor]

Shorts attacked the company and caused a meltdown of price and years worth of financing a few years ago. That had an ongoing and serious impact.

I think there is no denying what Adam Feierstein did in terms of false and disinformation efforts, false light posts and columns, this may, and it is doubtful that his fan boy collective of shorts did not take advantage of his generosity.

But nowhere have I posted that there is massive shorting keeping the price flat YTD. That would make no sense. In relation to the rest of the market and speculative bios generally, that is actually quite good for the year and doesn’t validate your claims.

The price has been flat YTD, the rest of the markets have collapsed. I am up at the current time approximately 60% per year for 5 years, so not seeing what you’re seeing.

[biosectinvestor]

The reality is social media direction is not valid. It just isn’t.

The regulators will analyze it properly, and so will the peer reviewed journal.

But your attempts here to imply fraud suggest a very unlikely set of facts, circumstances and conspiracies that are just highly unlikely.

[biosectinvestor]

Well said Sky!

[Dr Bala]

Nonsensical statements. DCVax-L will be approved based on the outstanding results of the P3 trial. The helmet will be obsolete.

[hoffmann6383]

any idea what 20% of 0 is?

go nwbo!

:)

[Poor Man -]

Horse, I’m coming to the noodle that broke the camel’s back scenario. Another Thanksgiving with nothing but ramen washed down with applejack might be my breaking point. The poor diet is affecting my liquidity and vision.

At today’s share price, I’ll probably keep 20% of my holdings just in case Linda and Les Clampett discover another oil well, i.e., Black Gold, Texas Tea, in their backyard.

through a ramen overdose reaction or

[hoffmann6383]

Not it if was up to Dr. Ashkan who was stumping for funding DCVax-L batch spun up after each recurrence. Lots of future trials are coming up.

[exwannabe]

And serious AEs specific to DCVAX? I don't believe so. Mono trials in the future will answer for sure.

I do not think many serious AEs will be due to DCVax-L.

We will never see a trial with DCVax-L and no other treatment. You can write that one in stone.

[LearningEveryTrade]

200k, by 5 years is 40k per year. Very very cheap. That is how NICE looks at things.

[SkyLimit2022]

HyGro, I wonder why you don’t go over to the NVCR message board and post cherry-picked SEC disclosures from their February 24th 2022 SEC filing. Their risk disclosures start on page 26 of the NovoCure filing posted below. You stated that SEC filings are submitted under penalty of perjury and should be considered by investors. I tend to believe that the documents as a whole are important, but we could follow your lead and pluck out some interesting risk statements to publish in isolation. What do you think?

https://d18rn0p25nwr6d.cloudfront.net/CIK-0001645113/c5eca622-306f-417f-931b-c2ab018fa6b6.pdf#page25

[LearningEveryTrade]

And serious AEs specific to DCVAX? I don't believe so. Mono trials in the future will answer for sure.

[hoffmann6383]

Exactly. We'll said.

[LearningEveryTrade]

Blabbering? Hello kettle, this is pot calling...lol

[hoffmann6383]

Yep, take it from Dr. Musella, approvals of DCVax-L are coming!

[hoffmann6383]

I agree, great news for longs that a highly successful and enormous family fund is putting their money into nwbo!

have a great one pal! by.

[biosectinvestor]

Because that is NORMAL. Not exactly sure what “dilution” to which you refer, but all dilution is necessary to be commercially viable and not go bankrupt at the pre-revenue stage. No shareholder is in a position to manage the company from a billion miles high. That’s why we have people who actually manage companies and make such decisions.

[biosectinvestor]

I have an example just the other day of how reasonable it would be if the company got only 15,000 patients for GBM alone in the markets it is in only currently, and how that could easily generate a substantial price per share with 1.5 billions shares outstanding. If it extends the indications beyond GBM to new and recurrent cancers in various indications, and assuming the Flaskworks scaling works in terms of manufacturing, which I have no reason to not expect, in a few years it certainly could reach a very substantial market cap, engage in share buybacks and reach a substantial per share value.

Plus you can have irrational enthusiasm as we see with Tesla.

[hoffmann6383]

Nonsense. It is 2022. Not 2011. We now have a completed trial, nearly certified commercial manufacturing, an approved PIP and approvable data per the experts.

have a good one pal. by.

[biosectinvestor]

That should read up almost 60% per year for 5 years, not up 60% total, I was quoting the comment made to me about what I had said previously, to respond, but the reply mischaracterized what I had said in numerous instances.

[exwannabe]

This time we might be in the 18th inning but our team has managed to put three men on base and the pitcher is tired, and our home team is energized and awaiting the 3-2 pitch!

Well, the good news is that next year we will see a pitch clock.

BTW, as far as "home stretch", from LP in CEO/CFO magazine in 2011

We are more than a decade into this. We spent more than a decade in clinical trials and we are now in what we hope will be the last clinical trial for the lead product that we have, which is an immune therapy for brain cancer. So, we are now on the home stretch.

With those financing mechanisms as well as some ongoing interest from investors who already have positions in the company, we feel like we are really strongly positioned financially for this home stretch push.

[exwannabe]

Nope.

A huge difference between the science and the regulatory side of the issue.

I see nothing in LP';s bio that says she is any sort of an expert on the latter.

[j e d]

at least you’re on record now explicitly stating you think you know the science better than Linda Liau. This presentation is not by NWBO, but a prominent scientist—an important difference.

[Horseb4CarT]

PM, I fear either you’re going through a ramen overdose reaction or I’m enjoying my daily red wine too much

You are obviously an intelligent person who has made it to the finest of the park bench neighborhood, and taking a profit of any size is better than a loss. So you do you and I respect you in any event.

As for me, I’m a sucker for a perceived bargain and a perma optimist, and although I have struck out several times before with bases loaded and two outs with the winning run being me at bat, I still like the opportunity of swinging for the fences!!!

This time we might be in the 18th inning but our team has managed to put three men on base and the pitcher is tired, and our home team is energized and awaiting the 3-2 pitch!

It’s at that moment I woke up

[exwannabe]

What does a gas guy who created an industry know about investing in a company creating an industry? Answer: A TON.

He obviously does not understand that DCVax-L is used in addition to chemo (after the initial chemo rad).

His blabbering about it being cheap compared to SOC is pointless when it is used in addition to SOC.

His blabbering about few/no AEs on treatment is BS as the patients are still taking chemo and have those AEs as well.

His statement that all previous GBM trials (since Stupp) failed makes clear he knows nothing about the space and is simply regurgitating SMA nonsense.

BTW, he did not create an industry. The US nat gas production increased fairly steady from 1950 to 1970. His company was formed in 1959,

[Dr Bala]

Checkmating after a highly successful P3 trial is an impossible task.

[ilovetech]

Well said.

[VikingInvest]

That, plus at this time there's not many other hideouts in the market. I think it will be another 3-4 weeks before we see a positive market shift. Hopefully be then we will have some news and maybe a small upward movement so people who have not yet de-risked their investment can get some of their cash out and have better overall market conditions to re-invest the money.

[Horseb4CarT]

I’m in over 12 years, probably 13 or 14 by now.

The evolving timelines and minimal communication, at least since 2015, have required a lot of patience and faith, however all recent indications are that we are in the final stretch that will provide greater visibility and ultimate approvals of DCVax-L for GBM.

Especially knowing that the phase 3 trial primary and secondary endpoints have been met with ample statistical significance, and that follow on combination trials are indicating promising efficacy and outstanding OS outcomes for an unheard of percentage of combo treatment recipients!!!

I made my decision to stick it out to the end many years ago and to go big or go home. I weigh all the due diligence constantly and my logic keeps coming back as favorable, understanding that nothing is guaranteed and life is full of extremely questionable decisions that somehow get made despite the evidence.

All imho

[ae kusterer]

CASES: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170094482

[laser777]

They have been doing this for years.

[Poor Man -]

The insiders at NVCR obviously know their company is over valued. No secret there. But NWBO’s lack of progress is not only offering them a longer runway to sell and capitalize at a higher share price, but also for insiders to receive additional bonus options, and I assume get past the vesting periods.

NVCR and their investors have made huge money with not much to show for it in terms of what they offer patients. I would say insiders at NVCR are laughing in the back of their limos on their long weekend drives to their homes in the Hamptons or the Vineyard — while I whistle my happy tunes on my park bench.

[Judge Smails 40]

Weekly Chart Update:
RSI continues to ride the Support Trend Line from Dec. As long as this holds, hard to get overly bearish. Circled the very thin weak part of the cloud upcoming in Nov. That's when I'm also predicting 50/200 Daily Golden Cross to happen. Bottom Long Term MACD Histogram 65,90,12 showing inside 20 EMA and Nice Trend of Higher Lows.

[LearningEveryTrade]

What does a gas guy who created an industry know about investing in a company creating an industry? Answer: A TON.

[Extremist223]

Hi Ex, I hope you can answer some of these questions, probably not the first one for obvious reasons.

How many dollars is the Crown Short $NWBO?



If the Crown was too short NWBO, who bears the burden of the debt? The taxpayer I assume, but what form would that take?

If a country was so short NWBO that they couldn't print away the problem, what decision would they make?

1) Try to talk down the buyout price?
2) Last minute hedge with a Coronetvirus?
3) Send me in to war? I'd be shooting at the Chinese but I'm long this stock with them. (highly likely)
4) Use citizen's assets as collateral because the taxpayer bears the burden of the debt?

The Prince of Wales' Coronet


Does Canada have a conscientious objector status? How can I be actively betting against my own Country and then be called a deserter and thrown in jail for refusing to fight? They would be saying, "we are not honouring the bet we have against you and we want you to fight for our bank account." That's gross after holding for years.

If you are actively betting against your own country because they took the opposite side, you should be able to consider yourself sovereign without becoming a citizen of another country. At that point why can't I renounce my citizenship? This is currently slavery. Canada's current laws require you to become a citizen of another country prior to renouncing, I assume so that they can deport you.

Why would Canada allow me to become a citizen of an Enemy country and leave freely? One day I may fight against Canada. Why would they not retain the worker in their country? He may not pay tax anymore, but he still contributes to the velocity of money and is productive.

So, is Canada stupid then? I have to be a citizen so that I pay taxes, so that I'm targeted by the Canada Pension Plan Investment Board, but I can become a member of the enemy team? I guess they leave that option open so it doesn't sound so bad.

If national strategies begin with citizens being exploited slaves, where does it end? You don't have to answer this one, the answer is that it doesn't end.

If White was doing good and black was doing bad, all we can do is make black moves.



"The system is broken, the world is in crisis, and things are about to get a lot worse, unless we change." - Justin Trudeau

Where is the Annual Shareholder Meeting?

Delaware virtual meetings are ass and allow a few tech companies to create infinite shell companies that you can't even sue (AI run companies). As soon as you catch on, they close up shop and move on to the next one.

Combine that with Swiss bank accounts and we have an entire SEC that look like scammers. That's America's way to scam us and say we don't know what's going on.

True Somewhere:
To sum up, they took my parent's taxes and shorted my success only to lose and send me in to shoot my real team and if I don't go I'm a deserter in jail. The Windsor PD really likes to say that they just follow protocol and the rules, HOW DO THE RULES SOUND NOW?

HOW CAN WE ONLY PLAY FROM THE DEVIL'S BLACK BOOK AND SING ABOUT GOD? Just another strat to throw you off track.

I think I'd rather talk about Goo-G Heapfind and the Soleilmana in my signature.

Maybe I really did end up on Earth 2 because I was sucked to hell :)

The bots could never come because they were too scared of their skill level :)

[hoffmann6383]

exactly.

[VikingInvest]

They are laughing all the way to the bank where they are collecting money for their shares before they lose more value.

[abeta]

a) that was awesome - thank you

b) hope you will continue to update as we move along the timeline

regards

[hoffmann6383]

Na, the insiders at NVCR are selling. The share price continues to spiral. All the while, NWBO remains flat YTD.

Not only are insiders selling but BMY is also cutting and running!

https://clinicaltrials.gov/ct2/show/NCT03430791?cond=glioblastoma+++Opdivo&draw=2&rank=5

NVCR is hurting.

[hoffmann6383]

Dr. Musella and the MHRA believe the ECA arm was done correctly. I'd like to see the resume of anyone that disagrees.

[Fireman02360]

The Management of small biotech Company's is very different than running a front-running technology company. The big difference is: You have the one of the largest regulatory bodies in the US Government (FDA) making the decision whether you can market and sell your product or not. You also have many more frivolous lawsuits filed in the biotech field than anywhere else on WS. Both of these "road-blocks" require Management to be much more tight-lipped about anything they may talk about and/or release in a PR. Its the nature of the beast and isnt confined to just NW Bio. Just about every other pre-revenue biotech company I have owned have act very similar. This isn't exclusive to NW Bio. There are wolves at every corner in the biotech space.

Biotech are regulated and hence the valuations don’t fly as high and as quickly as techs.

I couldn't disagree more and your statement makes me wonder if you truly know what you are talking about, and I am not saying that as an insult: Fortunes are sometimes made overnight in biotech. In chip/software/hardware tech, fortunes are made after many months and years. Its not uncommon for a small biotech to explode 200-500% in a single trading day, where as with above tech, its more of a slog, with the occasional 25-30% day, week or month. My biggest "hit" wasnt Nvidia even after all those years invested...it was biotech.....Anavex Life Sciences.$1.25 to $33 in pretty short order. With consumer tech, it takes many months and years to raise revenues and related earnings which equals a higher SP. In biotech, one bit of news (BLA approval for example) can raise earnings from zero to billions overnight.

-Fireman

[Poor Man -]

Not expecting that either, but would be nice.

I’m sure the guys at NVCR are laughing their rear-ends off right about now, watching this clown show.

[SkyLimit2022]

You exploit SEC filings to manufacture disinformation. Without its full context, any isolated SEC disclosure is a gross distortion of reality and is misleading. SEC filings are reliable, but they are SEC filings.

Research what these documents are and what their purpose is. Compare the SEC filings for other pre-commercial biotech companies and for well-established commercial companies. By comparison, in context, and with an informed perspective, you can understand their content and their actual significance.

Who on Earth has any guarantees of future events or full control over the choices and decisions of others? Is there any valuable company with zero risk? Apple? Tesla? Amazon? Pfizer? Even the best and the biggest have risks to report. NWBO is not yet commercial, yet you expect it to have fewer risks than a commercial giant?

SEC filings are solid sources. To ensure a proper and accurate understanding of their meaning, they must be read in full and in context. Furthermore, the publication date must be considered for perspective in light of subsequent developments and relevant new circumstances.

https://www.sec.gov/edgar/browse/?CIK=0001072379

https://www.merck.com/investor-relations/financial-information/sec-filings/

[Maverick0408]

We would be lucky if we get a pump this year. It will likely be next year when we are close to UK approvals. We will likely get slammed in the near term due to dilution and overall market dynamics. I’d be happy if we move in the positive direction though.

[fluteman]

Imagine November ... will be un-"bearable"